Next Level Urgent Care remains at the forefront of COVID-19 research and treatment
updated: Aug 12, 2021
August 12, 2021 (Newswire.com) –
Next Level Urgent Care (NLUC) continues to offer the latest in therapeutic options for the treatment of COVID-19. After participating in the earliest research studies of the Regeneron Monoclonal Antibody Infusion, the NLUC team is now proud to offer this incredible treatment in many of their clinic locations.
The Next Level Urgent Care health providers are committed to providing the best available medical care and services for all of their patients. “We are dedicated to ensuring that our community has access to cutting-edge treatments such as the Regeneron Monoclonal Antibody Infusions,” said Next Level Urgent Care founder and CEO Juliet Breeze, MD.
According to Breeze, the inpatient…